Literature DB >> 21240630

Relationships among the lactulose breath test, intestinal gas volume, and gastrointestinal symptoms in patients with irritable bowel syndrome.

Young Hoon Youn1, Jung Soo Park, Jae Hoon Jahng, Hyun Chul Lim, Jie-Hyun Kim, Mark Pimentel, Hyojin Park, Sang In Lee.   

Abstract

BACKGROUND AND AIMS: Irritable bowel syndrome (IBS) patients frequently complain of gas-related symptoms, and the lactulose breath test (LBT) is a test that assesses the amount of fermented gas generated by bacteria in the bowel. We aimed to assess the relationship among intestinal gas volume, LBT result, and gastrointestinal symptom score in healthy control and functional bowel disorder (FBD) subjects.
METHOD: In 84 IBS subjects, 24 FBD subjects other than IBS, and 25 healthy controls, a symptom questionnaire that enquired about seven main symptoms, plain abdominal radiography and a LBT were checked on the same day. The intestinal gas volume was calculated as the gas volume score (GVS) with a digitalized image of plain supine abdominal radiographs.
RESULTS: The GVS was greater in the LBT (+) group compared to the LBT (-) group (P = 0.02). The GVS was greater in the FBD and IBS groups than in the control group (P < 0.01). The GVS showed low but positive correlations with the severity and frequency of bloating, flatulence, abdominal pain, constipation, and tenesmus (P < 0.05). The severity of flatulence (P = 0.02) and the frequency of bloating (P = 0.02) in the LBT (+) group were significantly higher than those in the LBT (-) group.
CONCLUSIONS: Subjects with positive LBT had more gas-related symptoms and greater gas volume scores. Gas-related symptoms, positive LBT and increased GVS were significantly associated to each other. These findings can broaden the understanding of the pathophysiologic mechanisms of gas-related symptoms in IBS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21240630     DOI: 10.1007/s10620-011-1569-2

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  27 in total

1.  Activation of the mucosal immune system in irritable bowel syndrome.

Authors:  Vinton S Chadwick; Wangxue Chen; Dairu Shu; Barbara Paulus; Peter Bethwaite; Andy Tie; Ian Wilson
Journal:  Gastroenterology       Date:  2002-06       Impact factor: 22.682

2.  Intestinal gas and bloating: effect of prokinetic stimulation.

Authors:  Anna Accarino; Frederic Perez; Fernando Azpiroz; Sergi Quiroga; Juan-R Malagelada
Journal:  Am J Gastroenterol       Date:  2008-08       Impact factor: 10.864

3.  Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention.

Authors:  H Mertz; V Morgan; G Tanner; D Pickens; R Price; Y Shyr; R Kessler
Journal:  Gastroenterology       Date:  2000-05       Impact factor: 22.682

Review 4.  Abnormal breath testing in IBS: a meta-analysis.

Authors:  Eric D Shah; Robert J Basseri; Kelly Chong; Mark Pimentel
Journal:  Dig Dis Sci       Date:  2010-05-14       Impact factor: 3.199

5.  Germs, gas and the gut; the evolving role of the enteric flora in IBS.

Authors:  Eamonn M M Quigley
Journal:  Am J Gastroenterol       Date:  2006-02       Impact factor: 10.864

Review 6.  Intestinal motility in irritable bowel syndrome: is IBS a motility disorder? Part 1. Definition of IBS and colonic motility.

Authors:  D P McKee; E M Quigley
Journal:  Dig Dis Sci       Date:  1993-10       Impact factor: 3.199

Review 7.  Irritable bowel syndrome: epidemiology, diagnosis and treatment: an update for health-care practitioners.

Authors:  Oliver Grundmann; Saunjoo L Yoon
Journal:  J Gastroenterol Hepatol       Date:  2010-01-13       Impact factor: 4.029

Review 8.  Mechanisms of hypersensitivity in IBS and functional disorders.

Authors:  F Azpiroz; M Bouin; M Camilleri; E A Mayer; P Poitras; J Serra; R C Spiller
Journal:  Neurogastroenterol Motil       Date:  2007-01       Impact factor: 3.598

Review 9.  Pathophysiology underlying irritable bowel syndrome--from the viewpoint of dysfunction of autonomic nervous system activity.

Authors:  Noriaki Manabe; Toshiaki Tanaka; Jiro Hata; Hiroaki Kusunoki; Ken Haruma
Journal:  J Smooth Muscle Res       Date:  2009-02

Review 10.  Use and abuse of hydrogen breath tests.

Authors:  M Simrén; P-O Stotzer
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

View more
  5 in total

1.  Effects of daikenchuto, a Japanese herb, on intestinal motility after total gastrectomy: a prospective randomized trial.

Authors:  Yusuke Akamaru; Tsuyoshi Takahashi; Toshirou Nishida; Takeshi Omori; Kazuhiro Nishikawa; Shoki Mikata; Noriyuki Yamamura; Satoru Miyazaki; Hiroshi Noro; Shuji Takiguchi; Masaki Mori; Yuichiro Doki
Journal:  J Gastrointest Surg       Date:  2015-01-07       Impact factor: 3.452

2.  Analysis of exhaled volatile compounds following acute superior mesenteric artery occlusion in a pilot rat study.

Authors:  Juan Carlos Jimenez; Frank DeLano; James M Wilson; Brent A Kokubun; Robert S Bennion; Jesse E Thompson; Geert Schmid-Schonbein; Darin J Saltzman
Journal:  Ann Vasc Surg       Date:  2011-09-23       Impact factor: 1.466

Review 3.  Antibiotics for irritable bowel syndrome: rationale and current evidence.

Authors:  Amit H Sachdev; Mark Pimentel
Journal:  Curr Gastroenterol Rep       Date:  2012-10

4.  Differential effects of FODMAPs (fermentable oligo-, di-, mono-saccharides and polyols) on small and large intestinal contents in healthy subjects shown by MRI.

Authors:  Kathryn Murray; Victoria Wilkinson-Smith; Caroline Hoad; Carolyn Costigan; Eleanor Cox; Ching Lam; Luca Marciani; Penny Gowland; Robin C Spiller
Journal:  Am J Gastroenterol       Date:  2013-11-19       Impact factor: 10.864

5.  Microbiota stability in healthy individuals after single-dose lactulose challenge-A randomized controlled study.

Authors:  Sandra Y Wotzka; Markus Kreuzer; Lisa Maier; Mirjam Zünd; Markus Schlumberger; Bidong Nguyen; Mark Fox; Daniel Pohl; Henriette Heinrich; Gerhard Rogler; Luc Biedermann; Michael Scharl; Shinichi Sunagawa; Wolf-Dietrich Hardt; Benjamin Misselwitz
Journal:  PLoS One       Date:  2018-10-25       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.